Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Highly Accessed Research article

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50  doi:10.1186/ar3763

Accesses  

  • Last 30 days: 244 accesses
  • Last 365 days: 2667 accesses
  • All time: 5744 accesses